warburg pincus posts
FeedPosted Aug 6th 2008 9:44AM by Peter Cohan (RSS feed)
Filed under: JPMorgan Chase (JPM), Goldman Sachs Group (GS), Personal Finance, Politics
BusinessWeek reports that Wall Street has its eye on a new pot of cash -- your pension. And it's a mighty big pot -- $2.3 trillion. But Wall Street is not looking at the entire pension industry, just a $500 billion portion known as "frozen plans" that are closed to new employees and whose benefits are capped. McKinsey forecasts that frozen plans will triple to a hefty $1.5 trillion by 2013.
As usual, Wall Street's plan to buy these frozen pensions will line its own pockets and it will help companies as well. For example, if Wall Street charged a 2% management fee, that alone would generate $30 billion in revenues by 2013 if it bought all the frozen plans, but that fee income is probably the tip of the iceberg.
Companies are eager to dump their frozen pension plans. Why? These limping plans weigh down corporate balance sheet and new accounting rules will require companies to mark the value of their pension assets to market each quarter. In a down market, that could wipe out a company's operating profits.
Continue reading Does John McCain want to help Wall Street wipe out your pension?
Posted Jun 19th 2008 12:51PM by Jon Ogg (RSS feed)
Filed under: Deals, Raising money, Warburg Pincus, Engagements, Venture capital industry, Private equity industry, Investments, Public or private?

Most private equity firms hunt for stable companies with stable cash flows that are either cheap or inefficiently operated. These companies can then be resold for more money or taken public, or the strategy can fit into the Warren Buffett time frame of "forever." Biotechnology has long been the realm for only public companies, but that is changing.
Private equity firm
Warburg Pincus has
already made some biotech plays that seemed to be a harbinger of the trends here, and even more so when you consider foreign drug companies buying US-based biotechs on the cheap with that US Peso of a currency we have.
A new fund called GANIC Pharmaceuticals
has been launched this week, with Warburg Pincus as the main backer. the private equity firm made an initial investment in GANIC from the Warburg Pincus Private Equity X, L.P., a $15 billion fund which closed in April. As of now, we do not have any exact launch figures for the size of the investment that was given to GANIC.
GANIC's management is all former senior executives of MedPointe Pharmaceuticals and the company will will focus on building a substantial enterprise by acquiring revenue generating companies, portfolios, and/or products and by investing in innovation and acquiring pipeline development assets.
Read more at BioHealthInvestor.com for estimates of the size and strategies that the fund may employ.Posted Apr 22nd 2008 12:24PM by Tom Taulli (RSS feed)
Filed under: Private Equity, MBIA Inc (MBI)
Warburg Pincus, which is a top private equity firm, got its start over 40 years ago, bringing a professional approach to the business. Since then, the firm has invested $29 billion in more than 585 companies across 30 countries.
Well, now the firm has even more firepower for deals as it has raised a hefty $15 billion for its next fund. Some of its marquee investors include Washington State Investment Board and GE Asset Management.
But with the credit crunch, what can Warburg Pincus do with the money? Well, keep in mind that the firm has a growth orientation, which has less reliance on debt sources. What's more, Warburg Pincus has a global platform, which is particularly attractive to institutional investors.
Interestingly enough, Warburg Pincus has ventured into some distressed investing. The most notable transaction was a $1 billion investment in MBIA (NYSE: MBI), which suffered from bad timing (the deal was struck late last year).
But this doesn't seem to be much of a concern for Warburg Pincus. After all, the firm has undergone a variety of market cycles and realizes that real returns take time.
Tom Taulli is the author of various books, including The Complete M&A Handbook
and The Edgar Online Guide to Decoding Financial Statements
. He also operates MergerBook.com.
Posted Feb 11th 2008 10:00AM by Sheldon Liber (RSS feed)
Filed under: SEC Filings, Forecasts, Other Issues, Press Releases, Management, Market Matters, Bargain Stocks, MBIA Inc (MBI)
In an effort to raise additional cash and maintain its AAA credit rating, MBIA (NYSE: MBI), the largest insurer of debt, including municipal bonds, has decided to sell $1 billion of new shares. MBIA prices stock at $12.15 a share which is below Friday's closing price of $14.60. While there is concern by some that this will continue to dilute the value of these already beaten down shares, the market makers understand that maintaining the all important AAA credit rating is the foundation of the company.
Indeed, some analysts believe the stock has got twice its fair share of bad news holding it down based on book value, and have made predictions that the stock will see much better days. So much better, in fact, that analysts at Fox-Pitt Caronia are looking for a $26 to $28 price target in 12 months. I have no such crystal ball, but I do believe the stock will be higher at the end of the year. In the mean time, it is paying a 3.8% 10% yield.
The holders of the largest number of shares (and growing) Warburg Pincus, reports 16.5% MBIA stake, and is committed to $300 million of the offering. Over the weekend, the Motley Fools wrote a thin story, Why You Shouldn't Double Up, discussing large and small cap stocks and why if you hold index funds you may want to rethink your investment allocations. It included MBIA.
Sheldon Liber is the CEO of a small private investment company and the design and research principal for an architecture & planning firm. Disclosure: I am a long time shareholder of MBIA and purchased additional shares recently.
Posted Dec 10th 2007 2:38PM by Jonathan Berr (RSS feed)
Filed under: Major Movement, Private Equity, Economic Data, Housing, Federal Reserve

Shares of
MBIA Inc. (NYSE:
MBI) soared almost 30% after the world's largest bond insurer got a $1 billion cash infusion from
Warburg Pincus LLC, a private equity firm.
The money couldn't have come at a better time for Armonk, N.Y.-based MBIA, which faced a potentially crippling downgrade from the credit rating agencies As
Bloomberg News notes, "MBIA's AAA ranking stands behind $652 billion of state, municipal and structured finance bonds, and losing the AAA credit rating would endanger MBIA's ability to guarantee debt, its main source of revenue."
Under the terms of the agreement, Warburg Pincus will make an initial investment of $500 million through the acquisition of 16.1 million shares at $31 per share, a slight premium over Friday's closing. The investor will also backstop a shareholder rights offering of up to $500 million that MBIA expects to make next year. In addition, Warburg will receive warrants to purchase 8.7 million shares of MBIA common stock at a price of $40, and "B" warrants, which, upon obtaining certain approvals, will become exercisable to purchase 7.4 million shares of stock at $40.
Continue reading MBIA gets $1 billion lifeline from Warburg Pincus
Posted Dec 10th 2007 1:00PM by Jonathan Berr (RSS feed)
Filed under: Warburg Pincus, Investments

Shares of
MBIA Inc. (NYSE:
MBI) soared almost 30% after the world's largest bond insurer got a $1 billion cash infusion from
Warburg Pincus LLC, a private equity firm.
The money couldn't have come at a better time for Armonk, N.Y.-based MBIA, which faced a potentially crippling downgrade from the credit rating agencies As
Bloomberg News notes, "MBIA's AAA ranking stands behind $652 billion of state, municipal and structured finance bonds, and losing the AAA credit rating would endanger MBIA's ability to guarantee debt, its main source of revenue."
Under the terms of the agreement, Warburg Pincus will make an initial investment of $500 million through the acquisition of 16.1 million shares at $31 per share, a slight premium over Friday's closing. The investor will also backstop a shareholder rights offering of up to $500 million that MBIA expects to make next year. In addition, Warburg will receive warrants to purchase 8.7 million shares of MBIA common stock at a price of $40, and "B" warrants, which, upon obtaining certain approvals, will become exercisable to purchase 7.4 million shares of stock at $40.
Continue reading Warburg Pincus provides $1 billion infusion to MBIA
Posted Aug 2nd 2007 10:00AM by Paul Foster (RSS feed)
Filed under: Deals, Management, Warburg Pincus, Engagements
Bausch & Lomb (NYSE: BOL) -- volatility of 11 at low end of Range. BOL closed at $62.54. BOL announced it would be purchased by Warburg Pincus for $65 in cash on 5/16/07. Advanced Medical Optics Inc. (NYSE: EYE) announced yesterday it withdrew its offer to purchase BOL for $75. BOL over all option implied volatility is at 11 according to Track Data, suggests decreasing risk.
CheckFree (NASDAQ: CKFR) -- volatility Elevated prior to Fiserve Inc. (NYSE: FISV) paying $4.4 billion for CKFR. CKFR, an online banking, electronic payments, and financials infrastructure and services company, will be purchased by FISV for $48 a share in cash. CKFR will report EPS on August 9th. CKFR over all option implied volatility of 41 was above its 26-week average of 33 according to Track Data, suggesting larger risk.
Accredited Home Lenders (NASDAQ: LEND) -- volatility Spikes higher on Credit concerns. LEND, a mortgage company originating, financing, securitizing, servicing and selling non-prime mortgages, is recently down $2.14 to $6.07. Dow Jones said, "LEND on Thursday filed its delayed 2006 annual report, and raised concerns about its ability to continue to operate as a going concern." Lone Star announced on 6/4/07 it would acquire all of LEND's common stock for roughly $15 per share in cash. LEND September option implied volatility is above 225 according to Track Data, suggesting larger risk.
Daily M&A Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.
Posted May 16th 2007 3:24PM by Sarah Gilbert (RSS feed)
Filed under: Deals, Warburg Pincus, Bausch and Lomb, $3.7b, 2007
Bausch & Lomb Inc. (NYSE:
BOL) needed a savior, and today it announced it had found one in private equity firm
Warburg Pincus, which agreed to buy the troubled eyecare products company for $3.67 billion. It's a match that makes eminent sense: Warburg Pincus is the long-acknowledged master of health care finance, skilled at using its heft in the industry to orchestrate turnarounds of the small and mega varieties. Bausch & Lomb is plagued by product recalls which have delayed financial reporting and caused a major hit to the brand's reliability. What once was seen as a premium brand has fallen significantly in the eyes of the consumer -- and management hasn't yet shown any nimbleness in addressing its brand and accounting issues.
The purchase price, about $67.40 a share (Warburg Pincus will also assume $830 million of the company's debt), is only a small premium to the current price, and already the stock is up $5.75, or 9.3%, to $67.25 on the news. Analysts agree that the deal seems fair, and that going private for a bit makes sense for Bausch & Lomb -- it's not easy dealing with such huge issues in the public eye.
Meanwhile, members of the health care group at Warburg Pincus must be salivating for the chance to do every PE employee's favorite task: get strategical and really fix something.
Posted Apr 18th 2007 2:00PM by Tom Taulli (RSS feed)
Filed under: Rumors, Texas Pacific Group, Warburg Pincus, Public or private?

According to a
story in
Women's Wear Daily, it looks like Neiman Marcus' private equity owners --
Texas Pacific Group (TPG) and
Warburg Pincus -- are considering an IPO of the firm. They bought out the company back in 2005.
The IPO could come as early as this summer, although it's more likely to be early next year.
Neiman Marcus has been posting strong results lately. In the fiscal second quarter, sales increased 8.5% to $1.3 billion and operating earnings spiked from $69.7 million to $127.8 million. The company plans to expand the number of its stores to 50-52 by 2010, up from 44. Neiman has also been building out clearance centers, called Last Call.
There has been a drought in retail IPOs. But in light of TPG's highly successful IPO of
J. Crew (NYSE:
JCG), there's likely to be some interest in a Neiman Marcus offering.
Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.Posted Apr 18th 2007 12:48PM by Tom Taulli (RSS feed)
Filed under: Private Equity

According to a
story in Women's Wear Daily, it looks like Neiman Marcus' private equity owners --
Texas Pacific Group (TPG) and
Warburg Pincus -- are considering an IPO of the firm. They bought out the company back in 2005.
The IPO could come as early as this summer, although it's more likely to be early next year.
Neiman Marcus has been posting strong results lately. In the fiscal second quarter, sales increased 8.5% to $1.3 billion and operating earnings spiked from $69.7 million to $127.8 million. The company plans to expand the number of its stores to 50-52 by 2010, up from 44. Neiman has also been building out clearance centers, called Last Call.
There has been a drought in retail IPOs. But in light of TPG's highly successful IPO of J. Crew (NYSE: JCG), there's likely to be some interest in a Neiman Marcus offering.
For more news & views about private equity, please see BloggingBuyouts.Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.Posted Apr 13th 2007 1:36PM by Tom Taulli (RSS feed)
Filed under: Private Equity, JPMorgan Chase (JPM), Goldman Sachs Group (GS)

Billions keep flowing into private equity funds. The reason is simple. The funds -- especially the big ones -- have posted strong returns. Does this then mean that public shareholders are getting a raw deal?
Well, over the past few months, shareholders have been getting much more aggressive on buyouts. The latest example is the buyout of
Aramark. The company is a leader in providing food services, facilities management and even uniform apparel. There are roughly 240,000 employees.
Early this year, the company sold out to a variety of private equity firms, such as GS Capital Partners (NYSE:
GS), CCMP Capital Advisors, J.P. Morgan Partners (NYSE:
JPM), Thomas H. Lee Partners and
Warburg Pincus LLC. About 250 Aramark senior managers also invested in the deal.
The initial buyout price was $32 in cash, which was a bit of a disappointment for public shareholders and lawsuits ensued. This certainly
paid off as now, the buyers have agreed to a new price of $33.80. True, this does not sound like a lot, but it does amount to $222 million in extra consideration (the Delaware court approved the settlement this week).
It's also probably a sign of things to come in the buyout game.
Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.Posted Jan 24th 2007 12:46PM by Tom Taulli (RSS feed)
Filed under: Private Equity, Morgan Stanley (MS), Goldman Sachs Group (GS)

Dominion Resources Inc. (NYSE: D) is making some big changes. The company wants to unload about 83% of its oil and gas production business. The reserves are in areas such as New Mexico, the Permian Basin in Texas, the Gulf of Mexico and Canada.
Such a deal will carry a heavy price -- the estimate is $15 billion or so. But of course there is a ton of cash in the private equity sector and it looks like Dominion will have no trouble finding buyers.
According to the Wall Street Journal, one group includes firms like Madison Dearborn Partners, Warburg Pincus, First Reserve and Carlyle Group. And it looks like Goldman Sachs (NYSE: GS0) and Morgan Stanley (NYSE: MS) will also join the party.
Aren't these companies arch enemies?
Yes they are. But big-time deals require teamwork. Besides, Dominion's assets are top-notch and should be a strong source of ongoing cash flow generation as well as tax benefits.
And the interest in Dominion is another sign that private equity thinks that over the new few years energy prices should increase.
Tom Taulli is the author of various books, including the Complete M&A Handbook and the EDGAR-Online Guide to Decoding Financial Statements.
BloggingBuyouts is provided for informational purposes only. Nothing on the service is intended to provide personally tailored advice concerning the nature, potential, value or suitability of any particular security, portfolio or securities, transaction, investment strategy or other matter. You are solely responsible for any investment decisions that you make. The contributors who provide the content of BloggingBuyouts may, from time to time, hold positions in the securities discussed at the time of writing and they may trade for their own accounts. Such holdings will be disclosed at the time of writing. By using the site, you agree to abide to BloggingBuyouts' Terms of Use.